Psilera Bioscience
Pre-clinicalPsilera is a biotechnology company developing groundbreaking first-in-class treatments for neurological disorders by creating a new class of next-generation neuroplastogens.
Founded
2019
Focus
Small MoleculesPsychedelics
About
Psilera is a biotechnology company developing groundbreaking first-in-class treatments for neurological disorders by creating a new class of next-generation neuroplastogens.
Funding History
2Total raised: $2.3M
Grant$250KNational Science FoundationMay 15, 2022
Seed$2MUndisclosedAug 15, 2021
Company Info
TypePrivate
Founded2019
LocationTampa, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile